SG11202108821XA - Sghrt polypeptide and related products, methods and uses - Google Patents
Sghrt polypeptide and related products, methods and usesInfo
- Publication number
- SG11202108821XA SG11202108821XA SG11202108821XA SG11202108821XA SG11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA SG 11202108821X A SG11202108821X A SG 11202108821XA
- Authority
- SG
- Singapore
- Prior art keywords
- sghrt
- polypeptide
- methods
- related products
- products
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201901195V | 2019-02-12 | ||
| PCT/SG2020/050069 WO2020167252A1 (en) | 2019-02-12 | 2020-02-12 | Sghrt polypeptide and related products, methods and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108821XA true SG11202108821XA (en) | 2021-09-29 |
Family
ID=72045672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108821XA SG11202108821XA (en) | 2019-02-12 | 2020-02-12 | Sghrt polypeptide and related products, methods and uses |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12286460B2 (en) |
| EP (1) | EP3924366A4 (en) |
| CN (1) | CN113966341B (en) |
| SG (1) | SG11202108821XA (en) |
| WO (1) | WO2020167252A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025077853A1 (en) * | 2023-10-13 | 2025-04-17 | 南京安吉生物科技有限公司 | Organ fibrosis-related micropeptide (ofmp) and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030176681A1 (en) * | 1997-10-24 | 2003-09-18 | Ping Feng | 148 human secreted proteins |
| US20200080081A1 (en) * | 2016-12-14 | 2020-03-12 | Agency For Science, Technology And Research | A method for regulating the function of a heart cell, related nucleotides and compounds |
-
2020
- 2020-02-12 EP EP20755380.1A patent/EP3924366A4/en active Pending
- 2020-02-12 WO PCT/SG2020/050069 patent/WO2020167252A1/en not_active Ceased
- 2020-02-12 CN CN202080027644.3A patent/CN113966341B/en active Active
- 2020-02-12 SG SG11202108821XA patent/SG11202108821XA/en unknown
- 2020-02-12 US US17/430,484 patent/US12286460B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN113966341B (en) | 2024-09-17 |
| US12286460B2 (en) | 2025-04-29 |
| WO2020167252A1 (en) | 2020-08-20 |
| CN113966341A (en) | 2022-01-21 |
| EP3924366A4 (en) | 2023-01-04 |
| US20220227822A1 (en) | 2022-07-21 |
| EP3924366A1 (en) | 2021-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3660045T (en) | Polypeptide, process for the production thereof and use thereof | |
| IL277398A (en) | Pd-l1 binding affimers, and uses related thereto | |
| IL291299A (en) | Anti-tnfr2 antibodies, composotions comprising same and uses thereof | |
| SG11202103781TA (en) | Products, uses & methods | |
| IL287781A (en) | Clec12a-binding polypeptides and uses thereof | |
| GB2577981B (en) | Methods, products & Uses relating thereto | |
| ZA202103259B (en) | Modified cas9 protein, and use thereof | |
| GB2591554B (en) | Composiitons and methods and uses relating thereto | |
| IL287782A (en) | Cd33-binding polypeptides and uses thereof | |
| GB201905674D0 (en) | Aquafaba products and methods | |
| GB201813648D0 (en) | Methods, products & uses relating thereto | |
| IL287503A (en) | Thiosemicarbazates and uses thereof | |
| GB201819200D0 (en) | Polypeptide and uses thereof | |
| IL289955A (en) | Materials and methods for multidirectional biotransportation | |
| GB201802184D0 (en) | Products and methods | |
| IL287386A (en) | Promoter sequence and related products and uses thereof | |
| GB201902992D0 (en) | Product and method | |
| GB201900253D0 (en) | Catalysts and uses thereof | |
| SG11202108821XA (en) | Sghrt polypeptide and related products, methods and uses | |
| GB201912016D0 (en) | Methods, products & uses relating thereto | |
| IL268971A (en) | Polypeptide, polypeptide fragment, derivative thereof, and applications thereof | |
| GB201912021D0 (en) | Methods, products & Uses relating thereto | |
| GB201717345D0 (en) | Peptides, methods and apparatus | |
| ZA202005050B (en) | Polypeptide, compositions and uses thereof | |
| GB2583732B (en) | Methods and products |